Chemoinformaics analysis of ISOSAKURANETIN-7-RUTINOSIDE
| Molecular Weight | 432.425 | nRot | 4 |
| Heavy Atom Molecular Weight | 408.233 | nRig | 24 |
| Exact Molecular Weight | 432.142 | nRing | 4 |
| Solubility: LogS | -4.114 | nHRing | 2 |
| Solubility: LogP | 2.047 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 31 | No. of Aromatic Carbocycles | 2 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 12 |
| nHA | 9 | APOL | 59.961 |
| nHD | 4 | BPOL | 31.889 |
| QED | 0.564 |
| Synth | 3.921 |
| Natural Product Likeliness | 1.959 |
| NR-PPAR-gamma | 0.94 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.241 |
| HIA | 0.606 |
| CACO-2 | -5.991 |
| MDCK | 0.0000273 |
| BBB | 0.222 |
| PPB | 0.881687 |
| VDSS | 0.647 |
| FU | 0.0758079 |
| CYP1A2-inh | 0.038 |
| CYP1A2-sub | 0.307 |
| CYP2c19-inh | 0.15 |
| CYP2c19-sub | 0.628 |
| CYP2c9-inh | 0.073 |
| CYP2c9-sub | 0.884 |
| CYP2d6-inh | 0.475 |
| CYP2d6-sub | 0.724 |
| CYP3a4-inh | 0.124 |
| CYP3a4-sub | 0.206 |
| CL | 8.359 |
| T12 | 0.119 |
| hERG | 0.033 |
| Ames | 0.486 |
| ROA | 0.114 |
| SkinSen | 0.069 |
| Carcinogencity | 0.939 |
| EI | 0.019 |
| Respiratory | 0.551 |
| NR-Aromatase | 0.262 |
| Antiviral | Yes |
| Prediction | 0.692904 |